S1P1 receptor agonists for use in the treatment of multiple sclerosis

摘要

a S1 P1 receptor agonist of formula (I), or a pharmaceutically acceptable salt, or solvate, or N-oxide, or stereoisomer or deuterated derivate thereof, alone or combined with IFNβ, for use in the treatment of multiple sclerosis disease.